AstraZeneca — Clinical Trial Pipeline

AstraZeneca has 9 registered trials in the index.

Trials (9)

• Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium N/A · AstraZeneca
• Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment Phase 1 · AstraZeneca
• Study to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm Phase 2 · AstraZeneca
• Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Phase 4 · AstraZeneca
• Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) Phase 3 · AstraZeneca
• Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT) N/A · AstraZeneca
• Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies Phase 1 · AstraZeneca
• Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors Phase 1 · AstraZeneca
• NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART N/A · AstraZeneca

Related landscapes

• Carcinoma, Non-Small-Cell Lung
• Solid Tumours
• Non-small Cell Lung Cancer
• Locally Advanced Cervical Cancer
• Prostatic Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.